This study examines the changes in patient characteristics, valve types, and outcomes for isolated aortic valve replacements (AVRs) in North America over a 10-year period, from 1997 to 2006, using data from the Society of Thoracic Surgeons National Database. The analysis included 108,687 patients who underwent AVRs. Key findings include: 1. **Shift in Valve Types**: There was a significant increase in the use of bioprosthetic valves, which rose to 78.4% of all valves used, while the use of mechanical valves decreased to 20.5%. 2. **Patient Characteristics**: The patient population became older, with a mean age increase from 65.9 years in 1997 to 67.9 years in 2006. Patients were also more likely to have comorbidities such as obesity, diabetes, hypertension, chronic obstructive pulmonary disease, cerebrovascular disease, and renal failure. 3. **Outcomes**: Despite the increased risk factors, observed mortality and risk-adjusted mortality decreased by 24% and 33%, respectively. The incidence of stroke also decreased by 27%. 4. **Subgroup Analysis**: Female patients, those over 70 years old, and those with an ejection fraction less than 30% had higher mortality, stroke rates, and longer postoperative stays. Preoperative renal failure was associated with a 39% reduction in mortality. 5. **Discussion**: The study highlights improvements in surgical performance and outcomes for isolated AVRs, despite the aging and increasing risk profile of the patient population. The shift towards bioprosthetic valves may be influenced by factors such as younger patients' preference for non-anticoagulant options and the expected growth of the elderly population. 6. **Limitations**: The study is retrospective and based on voluntary participation, and it only focuses on AVRs, not other heart valve procedures. Long-term outcomes and health-related quality of life are not included in the analysis. Overall, the study demonstrates that while the patient population for AVRs has become more complex, the outcomes have improved, and there has been a notable trend towards using bioprosthetic valves.This study examines the changes in patient characteristics, valve types, and outcomes for isolated aortic valve replacements (AVRs) in North America over a 10-year period, from 1997 to 2006, using data from the Society of Thoracic Surgeons National Database. The analysis included 108,687 patients who underwent AVRs. Key findings include: 1. **Shift in Valve Types**: There was a significant increase in the use of bioprosthetic valves, which rose to 78.4% of all valves used, while the use of mechanical valves decreased to 20.5%. 2. **Patient Characteristics**: The patient population became older, with a mean age increase from 65.9 years in 1997 to 67.9 years in 2006. Patients were also more likely to have comorbidities such as obesity, diabetes, hypertension, chronic obstructive pulmonary disease, cerebrovascular disease, and renal failure. 3. **Outcomes**: Despite the increased risk factors, observed mortality and risk-adjusted mortality decreased by 24% and 33%, respectively. The incidence of stroke also decreased by 27%. 4. **Subgroup Analysis**: Female patients, those over 70 years old, and those with an ejection fraction less than 30% had higher mortality, stroke rates, and longer postoperative stays. Preoperative renal failure was associated with a 39% reduction in mortality. 5. **Discussion**: The study highlights improvements in surgical performance and outcomes for isolated AVRs, despite the aging and increasing risk profile of the patient population. The shift towards bioprosthetic valves may be influenced by factors such as younger patients' preference for non-anticoagulant options and the expected growth of the elderly population. 6. **Limitations**: The study is retrospective and based on voluntary participation, and it only focuses on AVRs, not other heart valve procedures. Long-term outcomes and health-related quality of life are not included in the analysis. Overall, the study demonstrates that while the patient population for AVRs has become more complex, the outcomes have improved, and there has been a notable trend towards using bioprosthetic valves.